Skip to main content
FARON PHARMACEUTICALS OY logo

FARON PHARMACEUTICALS OY — Investor Relations & Filings

Ticker · FARN ISIN · FI4000153309 LEI · 7437009H31TO1DC0EB42 IL Manufacturing
Open in API
Filings indexed 632 across all filing types
Latest filing 2026-06-03 Share Issue/Capital Cha…
Country FI Finland
Listing IL FARN

About FARON PHARMACEUTICALS OY

https://faron.com/

Faron Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for cancer. The company pioneers macrophage-targeting therapies to leverage the patient's immune system, aiming to address unmet medical needs and improve outcomes. Its lead asset, bexmarilimab, is a first-in-class anti-Clever-1 antibody and a myeloid cell-targeting immunotherapy candidate. Bexmarilimab is being investigated in clinical trials as a potential therapy for hematological malignancies and solid tumors, often in combination with standard-of-care treatments.

Recent filings

Filing Released Lang Actions
Faron Pharmaceuticals Ltd: Registration of New Shares
Share Issue/Capital Change Classification · 95% confidence The document is a company announcement reporting the registration of 3,366,377 new shares in the Finnish Trade Register, detailing the updated share count and treasury holdings. It constitutes a notification of share capital change via new share issuance rather than an earnings release, financial report, or general regulatory filing. This fits the “Share Issue/Capital Change” category.
2026-06-03 English
Faron Pharmaceuticals Ltd: Approval of Share Subscriptions Based on Special Rights in connection with Amortisation of the First and Second Tranche Bonds
Share Issue/Capital Change Classification · 82% confidence The document is a corporate announcement detailing the approval and issuance of 3,366,377 new shares in connection with the amortisation of two tranches of convertible bonds, including subscription pricing, share ranking, trading admission, and updated share counts. This is an announcement of a new share issue and capital change event, fitting the 'Share Issue/Capital Change' category (Code: SHA).
2026-06-03 English
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Major Shareholding Notification Classification · 88% confidence The document is a TR-1 standard form notifying an acquisition/disposal crossing a voting threshold, detailing percentage holdings, dates, and issuer information. This matches a Major Shareholding Notification. No financial statements or management commentary are included.
2026-06-01 English
FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY
Major Shareholding Notification Classification · 95% confidence The document is a standard notification of major holdings form filed by an institutional investor (Bank of America Corporation) for Faron Pharmaceuticals. It details crossing a shareholding threshold and provides percentages of shares and financial instruments held. This aligns precisely with the definition for a Major Shareholding Notification (MRQ) filing. There are no elements indicating an annual report, earnings release, or other category.
2026-05-28 English
Faron Pharmaceuticals Ltd: Issue of Treasury Shares to the Company
Share Issue/Capital Change Classification · 92% confidence The document is a company announcement detailing the Board’s resolution to issue 21,469,427 treasury shares (new shares to be held in treasury), the registration of those shares, and their admission to trading. This is a direct announcement of a share issue/capital change, fitting the "Share Issue/Capital Change" category (SHA).
2026-05-28 English
Faron Pharmaceuticals Ltd: Special Rights attached to the First and Second Tranche of Bonds
Capital/Financing Update Classification · 85% confidence The document is a company announcement detailing the board resolution to issue 8,000,000 Special Rights attached to bond tranches in deviation from pre-emptive rights. It describes a financing instrument issuance and a change in the company’s capital structure rather than presenting financial results, management changes, or regulatory filings. This is best classified as a Capital/Financing Update.
2026-05-28 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.